Kaiying Zhang Selected Research

Cytokines

6/2023

AdipoAI suppresses osteoclastogenesis by activating AdipoR1/APPL1: An in vivo experimental study in diabetes-associated peri-implantitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaiying Zhang Research Topics

Disease

4	Inflammation (Inflammations) 06/2023 - 01/2020
2	Periodontitis 01/2023 - 01/2022
1	Peri-Implantitis 06/2023
1	Bone Resorption 03/2023
1	Neoplasms (Cancer) 09/2022
1	Pneumonia (Pneumonitis) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Lung Injury 01/2020
1	type 1 Dentin dysplasia 12/2019
1	Postoperative Nausea and Vomiting (PONV) 10/2019
1	Acute Pain 10/2019
1	Nausea 10/2019
1	Pain (Aches) 10/2019
1	Postoperative Pain 10/2019
1	Vomiting 10/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioma (Gliomas) 01/2019

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
1	TitaniumIBA 06/2023
1	Adiponectin ReceptorsIBA 06/2023
1	CytokinesIBA 06/2023
1	6-Phytase (Phytase)IBA 03/2023
1	Phosphorus (Red Phosphorus)IBA 03/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	SelenocysteineIBA 09/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	ATPases Associated with Diverse Cellular ActivitiesIBA 12/2019
1	Analgesics (Analgesic Drugs)IBA 10/2019
1	AntiemeticsIBA 10/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2019
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2019
1	Midazolam (Versed)FDA LinkGeneric 01/2019
1	Flumazenil (Romazicon)FDA LinkGeneric 01/2019
1	BenzodiazepinesIBA 01/2019

Therapy/Procedure

1	Ligation 01/2023
1	Regenerative Endodontics 12/2019
1	Craniotomy 10/2019